Kara, O., Acar, S., & Elibol, T. . (2022). The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation. Medical Science and Discovery, 9(6), 324–333. https://doi.org/10.36472/msd.v9i6.743